SAN DIEGO, CA -- (MARKET WIRE) -- 06/20/2006 -- Althea Technologies, Inc., a leading provider of innovative technologies and services for pharmaceutical development and manufacturing, announced today that it has been awarded a contract from PowderMed, Ltd. to produce a Plasmid DNA-based vaccine to combat Influenza. PowderMed (Oxford, U.K.) is a private immunotherapeutic company focused on the clinical development and manufacture of therapeutic and prophylactic DNA-based vaccines for viral diseases and cancer.
